A 2.25 MIU colistin dose without a loading dose is SUBSTANTIALLY BELOW the recommended maintenance dose for an AKI patient and is inadequate for achieving therapeutic plasma concentrations.
Critical Dosing Issue
Your patient is receiving approximately half the recommended maintenance dose. According to the most recent 2022 international guidelines, the standard maintenance dose for critically ill patients is 4.5 MIU twice daily (9 MIU total daily dose), preceded by a 9 MIU loading dose 1. Your patient is receiving only 2.25 MIU per dose, which appears to be once daily based on typical practice patterns—this totals just 2.25-4.5 MIU daily depending on frequency, far below guideline recommendations.
Why This Matters for Mortality and Morbidity
The underdosing is particularly concerning because:
- Colistin requires a loading dose to rapidly achieve steady-state concentrations due to its pharmacokinetic properties. Without it, therapeutic levels may not be reached for 2-3 days, during which time the infection progresses 1, 2
- Subtherapeutic dosing increases mortality risk in severe infections caused by multidrug-resistant organisms, where colistin is often the last-resort option
- The presence of AKI does NOT eliminate the need for a loading dose—it only affects maintenance dosing adjustments 1, 3
Correct Dosing Algorithm for AKI Patients
Step 1: Determine if Loading Dose Was Given
- If NO loading dose given yet: Administer 9 MIU loading dose immediately (or 5 mg/kg if <60 kg) 1, 4
- Exception: For isolated urinary tract infections only, recent data suggests loading dose may be omitted, but this remains controversial 5
Step 2: Calculate Maintenance Dose Based on Creatinine Clearance
For patients NOT on renal replacement therapy:
The FDA-approved dosing and 2022 guidelines recommend 4, 1:
| CrCl (mL/min) | Maintenance Dose | Frequency |
|---|---|---|
| ≥80 | 4.5 MIU | Every 12 hours |
| 50-79 | 2.5-3.8 MIU | Every 12 hours |
| 30-49 | 2.5 MIU | Every 12-24 hours |
| 10-29 | 1.5 MIU | Every 36 hours |
For patients ON intermittent hemodialysis:
- Non-dialysis days: 1.5 MIU twice daily
- Dialysis days: 1.5 MIU twice daily PLUS 1.5 MIU supplemental dose after dialysis (total 4.5 MIU on HD days) 3
For patients ON continuous renal replacement therapy:
- Higher supplemental dosing needed due to drug removal
- Target maintenance: 4.5 MIU every 12 hours with adjustments based on effluent rates 2
Step 3: Monitor Renal Function Closely
This is a strong recommendation from all guidelines 1:
- Check serum creatinine daily during therapy
- AKI occurs in 14-70% of patients receiving colistin 6, 7, 8
- Risk factors for colistin-induced AKI include:
Critical Pitfalls to Avoid
Do NOT assume AKI means "use lower doses"—the maintenance dose should be adjusted based on CrCl, but therapeutic targets must still be met. Underdosing leads to treatment failure and mortality 1
Do NOT skip the loading dose in severe infections—even with AKI, the loading dose is essential for rapid attainment of therapeutic concentrations. The loading dose is NOT adjusted for renal function 1, 4
Do NOT use colistin monotherapy if alternatives exist—combination therapy (particularly with carbapenems) shows better outcomes in network meta-analyses, though evidence is mixed 1
Do NOT continue current dosing—2.25 MIU is inadequate even for the most severe renal impairment categories unless given every 36 hours in patients with CrCl 10-29 mL/min
Immediate Action Required
Reassess your patient's creatinine clearance immediately and adjust dosing according to the algorithm above. If this is a severe systemic infection (not isolated UTI), strongly consider giving the loading dose now if not previously administered, as the patient has likely been undertreated. The risk of treatment failure with current dosing substantially outweighs the incremental nephrotoxicity risk from appropriate dosing, especially since AKI is already present 1, 7.